Cargando…
1595. Accumulating Antiretroviral Therapy Safety Data In Pregnancy: Barriers To Clinician Reporting To The Antiretroviral Pregnancy Registry In North America And Internationally
BACKGROUND: Clinical trials evaluating antiretroviral therapy (ARV) often exclude pregnant women, delaying the accumulation of safety data in pregnancy, and use of newer ARVs in women of reproductive age. The Antiretroviral Pregnancy Registry (APR) is the largest international exposure registry of A...
Autores principales: | Stavroula manta, M, O’Bryan, Jessica, Giles, Michelle, Short, William R, logue-Chamberlain, Erin, Krishnaswamy, sushena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677065/ http://dx.doi.org/10.1093/ofid/ofad500.1430 |
Ejemplares similares
-
74. Maternal Dolutegravir (DTG) Use During Pregnancy and Birth Outcomes: The Antiretroviral Pregnancy Registry (APR)
por: Vannappagari, Vani, et al.
Publicado: (2021) -
The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review
por: Giles, Michelle L., et al.
Publicado: (2018) -
Antiviral and antiretroviral use in pregnancy
por: Money, Deborah M
Publicado: (2003) -
Safety and Tolerability of Antiretrovirals during Pregnancy
por: Weinberg, Adriana, et al.
Publicado: (2011) -
Factors Associated with Early Versus Late Uptake of the COVID-19 Vaccine during Pregnancy over Time in Australia: A Population-Based Cohort Study
por: Giles, Michelle L., et al.
Publicado: (2023)